Table GPS-1. Lifetime prevalence of drug use among all adults (aged 15 to 64) in nationwide surveys among the general population – Part (i) Lifetime prevalence all adults (percentage)

Country – geographical area

Year

Ref.

Age range all adults

Sample size all adults

Cannabis (%)

Cocaine (%) (1)

Amphetamines (%) (2)

Ecstasy (%) (3)

LSD (%)

Belgium

Flemish Community (Brussels excluded)

 

1994

(1)

18-65

2259

5.8

0.5

0.9

0.5

 

French-speaking Community

 

1996-97

(2)

18-49

976

12.8

 

 

 

 

French-speaking Community

 

1998-99

(3)

18-49

1008

20.3

 

 

 

 

French-speaking Community

 

2000

(4)

18-49

694

22.2

 

 

 

 

National

 

2001

(5)

15-64

7347

10.6

 

2.1

 

 

Czech Republic

National

 

2002

(1)

18-64

2526

21.1

 

2.3

4.0

2.2

National

 

2004

(2)

18-64

3526

20.6

1.1

2.5

7.1

1.4

Denmark

 

 

 

 

 

 

 

 

 

 

National

 

1990

(1)

>=16

2000

22.0

1.0

3.0

 

 

National

 

1994

(2)

 

 

 

 

 

 

 

National

 

2000

(3)

16-64

11825

31.3

2.5

5.9

1.0

1.4

Germany

East Germany

 

1990

(1)

 

 

 

 

 

 

 

Western Germany

 

1990

(2)

 

 

 

 

 

 

 

Old and New Länder

 

1995

(3)

18-59

7833

11.9

1.9

2.4

1.4

 

Old and New Länder

 

1997

(4)

18-59

8019

11.5

1.4

1.5

1.5

 

National

 

2000

(5)

18-59

8139

19.3

2.3

2.3

1.6

1.8

National

 

2003

(6)

18-59

8061

24.5

3.2

3.4

2.4

2.5

Estonia

 

 

 

 

 

 

 

 

 

 

National

 

1998

(1)

18-64

2317

5.0

1.0

1.0

1.0

 

National

 

2003

(2)

 

 

 

 

 

 

 

Greece

Athens

 

1993

(1)

12-64

2103

9.4

0.8

1.0

 

 

National (except Aegean and Ionian Islands)

 

1998

(2)

15-64

3398

13.1

1.3

0.6

0.3

 

National (except Aegean and Ionian Islands)

 

2004

(3)

15-64

4351

8.9

0.7

0.1

0.4

0.3

Spain

National

 

1995

(1)

15-64

8888

14.2

3.7

2.5

2.0

 

National

 

1997

(2)

15-65

12515

21.7

3.2

2.6

2.5

 

National

 

1999

(3)

15-64

12234

19.8

3.2

2.2

2.4

 

National

 

2001

(4)

15-64

14113

24.5

4.9

3.0

4.2

 

National

 

2003

(5)

15-64

12033

29.0

5.9

3.2

4.6

 

France

National

 

1992

(1)

15-64

2099

11.3

0.7

 

 

 

Metropolitan France

 

1995

(2)

18-75

1787

16.0

1.2

0.7

 

 

National

 

1999

(3)

18-69

1742

21.9

1.5

0.2

0.9

1.2

National

 

2000

(4)

15-64

11317

22.5

1.6

1.5

0.9

1.7

Metropolitan France

 

2002

(5)

15-64

1744

26.2

2.2

0.4

0.9

1.2

Ireland

National

 

1998

(1)

18-64

826

14.3

 

 

 

 

National

 

1998

(2)

18-64

 

19.9

 

 

 

 

National

 

2000

(3)

18-64

907

11.3

 

 

 

 

National

 

2002-03

(4)

15-64

4918

17.4

3.0

3.0

3.7

2.9

Italy

National

 

2001

(1)

15-44

6032

21.9

3.4

1.5

1.8

0.0

National

 

2003

(2)

15-54

11869

22.4

4.6

1.9

1.8

2.1

Cyprus

National

(4)

2003

(1)

15-65

1000

19.8

1.1

1.4

4.3

0.2

Latvia

National

 

2003

(1)

15-64

4534

10.6

1.2

2.6

2.4

1.1

Lithuania

National

 

2004

(1)

15-64

4207

7.6

0.4

1.1

1.0

0.3

Luxembourg

National

 

1998

(1)

15-64

 

12.9

0.2

 

1.2

1.4

Hungary

National

 

2001

(1)

18-65

2359

5.7

0.8

1.6

2.0

1.6

National

 

2003

(2)

18-54

 

9.8

1.0

2.5

3.1

1.7

Malta

National

 

2001

(1)

18-64

 

3.5

0.4

0.4

0.7

0.5

Netherlands

National

 

1997-98

(1)

15-64

17590

19.1

2.6

2.2

2.3

1.5

National

 

2001

(2)

15-64

14045

21.0

3.6

3.1

3.6

1.3

Austria

National

 

2004

(1)

15-64

3980

20.1

2.3

2.4

3.0

1.7

Poland

National

 

2002

(1)

16-64

 

7.7

0.8

1.9

0.7

1.2

Portugal

National

 

2001

(1)

15-64

14186

7.6

0.9

0.5

0.7

0.4

Slovakia

National

 

2002

(1)

18-64

1405

14.9

1.0

0.8

1.8

 

National

 

2004

(2)

15-64

1315

15.6

1.1

1.5

4.0

 

Finland

National

 

1992

(1)

18-74

3457

4.9

 

0.2

 

 

National

 

1996

(2)

16-74

3009

7.3

 

0.7

 

 

National

 

1998

(3)

15-69

2568

9.7

0.6

1.0

0.5

 

National

 

2000

(4)

15-64

1677

9.9

0.6

1.0

0.6

0.4

National

 

2002

(5)

15-64

2377

12.8

0.7

2.2

1.4

0.8

National

 

2004

(6)

15-64

2352

12.9

1.2

1.9

1.4

0.7

Sweden

National

 

1994

(1)

16-64

806

7.1

0.4

1.4

0.0

0.4

National

 

1996

(2)

16-64

1136

9.8

1.0

2.1

0.3

0.2

National

 

1998

(3)

16-64

1359

13.9

0.6

2.0

0.3

 

National

 

2000

(4)

16-64

1750

12.5

0.7

1.9

0.2

0.3

National

 

2004

(5)

18-64

9514

13.8

 

 

 

 

National

 

2005

(6)

16-64

30538

11.9

 

 

 

 

United Kingdom

England and Wales

 

1994

(1)

16-59

9645

21.0

2.4

8.2

2.4

4.4

England and Wales

 

1996

(2)

16-59

10935

23.5

3.1

9.3

3.8

5.4

England and Wales

 

1998

(3)

16-59

9984

26.8

3.8

10.8

4.2

5.6

England and Wales

 

2000

(4)

16-59

13018

29.5

5.6

12.3

5.3

6.2

England and Wales

 

2001-02

(5)

16-59

20165

28.9

5.2

11.6

5.9

5.4

England and Wales

 

2002-03

(6)

16-59

23586

30.6

6.2

12.3

6.6

5.9

England and Wales

 

2003-04

(7)

16-59

24422

30.8

6.8

12.2

6.9

6.1

England and Wales

 

2004-05

(8)

16-59

28509

29.7

6.1

11.2

6.7

5.1

Northern Ireland

 

2002-03

(9)

15-64

3516

16.8

1.6

4.0

5.8

4.5

Scotland

 

2003

(10)

16-64

3506

21.0

4.6

8.9

5.5

4.3

United Kingdom

 

2004

(11)

 

35707

29.6

6.5

11.7

6.7

5.9

Bulgaria

National

 

2005

(1)

18-60

1036

4.4

1.1

1.4

1.3

0.8

Romania

National

 

2004

(1)

15-64

 

1.7

0.4

0.2

0.3

0.2

Norway

National

 

1999

(1)

15-64

1803

15.3

2.2

3.8

1.3

 

National

 

2004

(2)

15-64

2669

16.2

2.7

3.6

1.8

1.1

Notes:

(1) Cocaine in any form.

(2) For Belgium National 2001 and for Metropolitan France 1995: amphetamines and ecstasy.

(3) For Spain: ecstasy and other designer drugs.

(4) Results of this survey should be viewed with caution due to important discrepancies with previous surveys and school survey results. A new survey with a bigger sample was conducted in 2005.

This table aims to present an overview of national surveys. Exceptionally, some relevant regional surveys are presented. Some city surveys reported by countries were not included as they tend to produce higher prevalence estimates which are not comparable with estimates for whole countries (or large regions with both urban and rural areas). Athens was included as reference point for the 1993 survey.

In surveys with small sample sizes results should be interpreted with caution.

Countries were asked to report results using, as far as possible, EMCDDA standard age groups (all adults: 15-64, young adults: 15-34). In countries where age ranges are more restrictive, prevalence estimates tend to be slightly higher. Some countries have recalculated their prevalence figures using the EMCDDA standard age groups.

For methods and definitions on population surveys in general, see General population surveys of drug use – methods and definitions.

For methods of each survey presented in this table, see Table GPS-1 part (ii).

See also 'General notes for interpreting data' on the Explanatory notes and help page.

Sources:

See Table GPS-0

Data filter | gpstab02a-en.xml